PatientCite Check
A clinical-decision-support add-on that double-checks which regions of a medical image, lab report, or clinical note an AI diagnosis system actually used, and warns the clinician if that grounding shifted after a recent model update.
Hospital radiology departments and clinical informatics teams running AI diagnostic tools
- Pre/post-update grounding comparison showing exactly which image regions or note spans informed each diagnosis
- Per-finding confidence plus evidence-channel breakdown (image, lab, history) on every AI suggestion
- Clinician-facing diff view that highlights when the AI's cited evidence moved between versions
- HITRUST-friendly deployment that keeps PHI and image data inside the hospital perimeter
Multimodal diagnostic AI is being retrained frequently, and silent evidence drift could change which tumor region or lab value actually drove a recommendation — exactly the kind of mistake no one notices until it hits a patient.
Active concern documented: JACR article calls for stopping AI drift, arXiv 2410.13174 introduces MMC+ drift monitoring, and a ScienceDirect framework explicitly targets ongoing surveillance of clinical AI — but buyer urgency is still emerging, not yet mainstream procurement.Postdeployment Monitoring of Artificial Intelligence in Radiology: Stop... ↗Scalable Drift Monitoring in Medical Imaging AI (MMC+) ↗
No vendor found that specifically checks evidence/grounding (saliency, cited regions, lab values) drift across model versions. Existing tools (CheXstray/MMC+) monitor accuracy/embedding drift, not feature-attribution shift — leaving a clear, narrow gap.Scalable Drift Monitoring in Medical Imaging AI (MMC+) ↗Does It Work, Help, and Stay? A Framework for Implementing Artificial Intelligence ↗
FDA's PCCP guidance effectively mandates post-update surveillance for AI/ML SaMD, creating regulatory pull, and Nature's systematic review confirms hospitals are allocating budget to clinical AI. However, this is a compliance/risk-reduction add-on — a smaller ticket than diagnostic AI itself, with limited near-term willingness-to-pay evidence.Marketing Submission Recommendations for a Predetermined Change Control Plan for AI-Enabled Devices ↗Systematic review of cost effectiveness and budget impact of clinical AI ↗
Regulatory tailwind is durable: FDA PCCP framework bakes monitoring into the lifecycle of every adaptive AI device, and the radiology AI market is forecast to expand through 2030. Grounding/explainability scrutiny is a multi-year, structural requirement — not a trend.Radiology AI Market Report 2025-2030 ↗
Technically non-trivial: requires hooking into each vendor's diagnostic model to extract saliency/citations, comparing attributions across versions, and integrating into PACS/clinical workflow. Research-grade attribution comparison plus fragmented hospital procurement makes this a multi-year build, not a weekend MVP.Scalable Drift Monitoring in Medical Imaging AI (MMC+) ↗